- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-190X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacovigilance Considerations for Biosimilars in the USA ; volume:29 ; number:5 ; day:29 ; month:9 ; year:2015 ; pages:309-321 ; date:10.2015
BioDrugs ; 29, Heft 5 (29.9.2015), 309-321, 10.2015
- Creator
-
Grampp, Gustavo
Felix, Thomas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-015-0137-2
- URN
-
urn:nbn:de:101:1-2019120120163678500558
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grampp, Gustavo
- Felix, Thomas
- SpringerLink (Online service)
Other Objects (12)
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Biosimilars : Handbuch
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
An Efficient Development Paradigm for Biosimilars
Current perspectives on biosimilars
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Biosimilars in hematology and oncology
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Biosimilars : Handbuch
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
An Efficient Development Paradigm for Biosimilars
Current perspectives on biosimilars
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Biosimilars in hematology and oncology
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Biosimilars : Handbuch
Developing the Totality of Evidence for Biosimilars: Regulatory Considerations and Building Confidence for the Healthcare Community
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
An Efficient Development Paradigm for Biosimilars
Current perspectives on biosimilars
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology